From a market taxonomy perspective, the type classification of wound‑type supercapacitors delineates the technological pathways that sustain each application segment. Symmetric supercapacitors, built from identical electrode materials, dominate the low‑cost, high‑cycle‑life niche and contribute roughly 40 % of overall capacity, particularly in wearable sensors where cost sensitivity outweighs energy density. Asymmetric supercapacitors, employing a high‑capacitance positive electrode and a carbon‑based negative electrode, capture about 30 % of the market; their broader voltage window makes them suitable for wound‑healing devices that require sustained therapeutic pulses. Hybrid supercapacitors, which combine a battery‑type faradaic electrode with a conventional double‑layer electrode, account for an estimated 20 % share, aligning with cardiac‑monitoring systems that benefit from higher energy density while retaining rapid power delivery. Solid‑state supercapacitors, featuring electrolyte‑free architectures, hold the remaining 10 % and are gaining traction in drug‑delivery platforms where leakage‑free operation and biocompatibility are paramount. The distribution of these types reflects the engineering trade‑offs—cost, power density, voltage range, and safety—that each application imposes on the Wound Type Supercapacitor segmentation.